New Zealand markets closed

UnitedHealth Group Incorporated (UNH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
303.23+0.73 (+0.24%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5288.17B
Enterprise value 3313.37B
Trailing P/E 17.04
Forward P/E 116.38
PEG ratio (5-yr expected) 11.44
Price/sales (ttm)1.16
Price/book (mrq)4.53
Enterprise value/revenue 31.26
Enterprise value/EBITDA 611.83

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 339.60%
S&P500 52-week change 310.81%
52-week high 3324.57
52-week low 3187.72
50-day moving average 3310.19
200-day moving average 3290.78

Share statistics

Avg vol (3-month) 32.78M
Avg vol (10-day) 33.15M
Shares outstanding 5950.34M
Float 944.53M
% held by insiders 10.71%
% held by institutions 189.92%
Shares short (14 Sep 2020) 45.19M
Short ratio (14 Sep 2020) 41.97
Short % of float (14 Sep 2020) 40.55%
Short % of shares outstanding (14 Sep 2020) 40.55%
Shares short (prior month 13 Aug 2020) 45.47M

Dividends & splits

Forward annual dividend rate 45
Forward annual dividend yield 41.65%
Trailing annual dividend rate 34.49
Trailing annual dividend yield 31.48%
5-year average dividend yield 41.45
Payout ratio 425.24%
Dividend date 321 Sep 2020
Ex-dividend date 410 Sep 2020
Last split factor 22:1
Last split date 330 May 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020


Profit margin 6.90%
Operating margin (ttm)9.82%

Management effectiveness

Return on assets (ttm)8.46%
Return on equity (ttm)27.62%

Income statement

Revenue (ttm)247.81B
Revenue per share (ttm)261.27
Quarterly revenue growth (yoy)2.50%
Gross profit (ttm)57.6B
Net income avi to common (ttm)17.1B
Diluted EPS (ttm)17.79
Quarterly earnings growth (yoy)101.50%

Balance sheet

Total cash (mrq)25.59B
Total cash per share (mrq)26.93
Total debt (mrq)46.06B
Total debt/equity (mrq)67.38
Current ratio (mrq)0.79
Book value per share (mrq)66.97

Cash flow statement

Operating cash flow (ttm)22.3B
Levered free cash flow (ttm)17.04B